Dow Up 0.11% Nasdaq Up 0.50%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
169.29 Up 0.98(0.58%) Aug 29, 3:59PM EDT
|After Hours : 169.26 Down 0.01 (0.01%) Aug 29, 4:23PM EDT
Prev Close:168.31
Open:169.58
Bid:167.53 x 100
Ask:195.69 x 200
1y Target Est:197.05
Beta:0.62
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:167.18 - 169.80
52wk Range:100.89 - 185.43
Volume:703,599
Avg Vol (3m):1,149,950
Market Cap:33.49B
P/E (ttm):102.35
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 0.58%33.49B
AMGNUp 0.50%105.87B
BAXUp 0.09%40.61B

Key Statistics

Forward P/E (1 yr):29.29
P/S (ttm):17.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback